Evidence map›Paper›PMID 29967595›Full record

ArticleFrontiers in microbiology2018

Establishment of an Endogenous

Kentaro Oka, Takako Osaki, Tomoko Hanawa, Satoshi Kurata, Emi Sugiyama, Motomichi Takahashi, Mamoru Tanaka, Haruhiko Taguchi, Shigeru Kamiya

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Pathogens (Basel, Switzerland) · 2024
    Review
  7. Frontiers in microbiology · 2024
    Article
  8. Probiotics: insights and new opportunities forCritical reviews in microbiology · 2023
    Review
  9. Article
  10. Microbial ecology betweenBioscience of microbiota, food and health · 2023
    Review
  11. Review
  12. Effect ofBiomedicines · 2022
    Review
  13. Bioscience of microbiota, food and health · 2022
    Article
  14. Article
  15. Administration ofNutrients · 2021
    Article
  16. Application of Microbiome Management in Therapy forPathogens (Basel, Switzerland) · 2021
    Review
  17. Article
  18. The Effect ofFrontiers in microbiology · 2019
    Article
  19. Is primary prevention ofBioscience of microbiota, food and health · 2019
    Article
  20. .Clostridioides difficile.Trends in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kentaro OkaTokyo R&D Center, Miyarisan Pharmaceutical Co., Ltd., Tokyo, Japan.
Takako OsakiDepartment of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.
Tomoko HanawaDepartment of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.
Satoshi KurataDepartment of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.
Emi SugiyamaResearch Laboratory, Miyarisan Pharmaceutical Co., Ltd., Nagano, Japan.
Motomichi TakahashiTokyo R&D Center, Miyarisan Pharmaceutical Co., Ltd., Tokyo, Japan.
Mamoru TanakaResearch Laboratory, Miyarisan Pharmaceutical Co., Ltd., Nagano, Japan.
Haruhiko TaguchiDepartment of Immunology, Kyorin University Faculty of Health Sciences, Tokyo, Japan.
Shigeru KamiyaDepartment of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.
Kyorin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

C. difficile associated diarrheaC. difficile infection modelClostridium butyricumClostridium difficileprobiotics

Identifiers

PMID29967595
PMCPMC6015907
OpenAlexW2804536701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.